Copyright Reports & Markets. All rights reserved.

Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Alzheimer's Disease Therapeutics and Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Biomarkers
    • 1.4.3 Cholinesterase inhibitors
    • 1.4.4 NMDA receptor antagonists
    • 1.4.5 Brain imaging
    • 1.4.6 Blood tests
  • 1.5 Market by Application
    • 1.5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Drugs Market
    • 1.5.3 Diagnostics Market
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Regions
    • 2.2.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Alzheimer's Disease Therapeutics and Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Alzheimer's Disease Therapeutics and Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Market Size
    • 3.1.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio
    • 3.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2019
  • 3.3 Alzheimer's Disease Therapeutics and Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 6.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 7.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 8.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in China (2019-2020)
  • 8.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 9.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 10.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 11.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in India (2019-2020)
  • 11.3 India Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2015-2020)
  • 12.2 Alzheimer's Disease Therapeutics and Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Namenda
    • 13.1.1 Namenda Company Details
    • 13.1.2 Namenda Business Overview
    • 13.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020))
    • 13.1.5 Namenda Recent Development
  • 13.2 Aricept
    • 13.2.1 Aricept Company Details
    • 13.2.2 Aricept Business Overview
    • 13.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.2.5 Aricept Recent Development
  • 13.3 Exelon
    • 13.3.1 Exelon Company Details
    • 13.3.2 Exelon Business Overview
    • 13.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.3.5 Exelon Recent Development
  • 13.4 Solanezumab
    • 13.4.1 Solanezumab Company Details
    • 13.4.2 Solanezumab Business Overview
    • 13.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.4.5 Solanezumab Recent Development
  • 13.5 Gantenerumab
    • 13.5.1 Gantenerumab Company Details
    • 13.5.2 Gantenerumab Business Overview
    • 13.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.5.5 Gantenerumab Recent Development
  • 13.6 Verubecestat
    • 13.6.1 Verubecestat Company Details
    • 13.6.2 Verubecestat Business Overview
    • 13.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.6.5 Verubecestat Recent Development
  • 13.7 Pfizer
    • 13.7.1 Pfizer Company Details
    • 13.7.2 Pfizer Business Overview
    • 13.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.7.5 Pfizer Recent Development
  • 13.8 Eisai
    • 13.8.1 Eisai Company Details
    • 13.8.2 Eisai Business Overview
    • 13.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.8.5 Eisai Recent Development
  • 13.9 Actavis
    • 13.9.1 Actavis Company Details
    • 13.9.2 Actavis Business Overview
    • 13.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.9.5 Actavis Recent Development
  • 13.10 Lundbeck
    • 13.10.1 Lundbeck Company Details
    • 13.10.2 Lundbeck Business Overview
    • 13.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 13.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 13.10.5 Lundbeck Recent Development
  • 13.11 Daiichi Sankyo
    • 10.11.1 Daiichi Sankyo Company Details
    • 10.11.2 Daiichi Sankyo Business Overview
    • 10.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 10.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 10.11.5 Daiichi Sankyo Recent Development
  • 13.12 Novartis
    • 10.12.1 Novartis Company Details
    • 10.12.2 Novartis Business Overview
    • 10.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 10.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 10.12.5 Novartis Recent Development
  • 13.13 TauRx
    • 10.13.1 TauRx Company Details
    • 10.13.2 TauRx Business Overview
    • 10.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction
    • 10.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2015-2020)
    • 10.13.5 TauRx Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Alzheimer's Disease Therapeutics and Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Namenda
    Aricept
    Exelon
    Solanezumab
    Gantenerumab
    Verubecestat
    Pfizer
    Eisai
    Actavis
    Lundbeck
    Daiichi Sankyo
    Novartis
    TauRx

    Market segment by Type, the product can be split into
    Biomarkers
    Cholinesterase inhibitors
    NMDA receptor antagonists
    Brain imaging
    Blood tests
    Market segment by Application, split into
    Drugs Market
    Diagnostics Market

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now